Edition:
United Kingdom

People: Enzo Biochem Inc (ENZ.N)

ENZ.N on New York Stock Exchange

3.58USD
18 Apr 2019
Change (% chg)

$0.00 (+0.00%)
Prev Close
$3.58
Open
$3.56
Day's High
$3.64
Day's Low
$3.50
Volume
88,335
Avg. Vol
46,498
52-wk High
$6.88
52-wk Low
$2.33

Perlysky, Dov 

Mr. Dov Perlysky is Independent Director of Enzo Biochem, Inc. He is currently a member of the Company’s Audit, Compensation and Nominating and Corporate Governance Committees. Mr. Perlysky became the chairman of the Compensation Committee in 2017. Mr. Perlysky has been a member of the Board of Directors of Pharma-Bio Serv, Inc. since 2004, Highlands State Bank since 2010 and News Communications since 2007. Mr. Perlysky has also been the managing member of Nesher, LLC, a private investment firm, since 2000 and a director of Engex, Inc., a closed-end mutual fund, since 1999. From 1998 until 2002, Mr. Perlysky was a vice president in the private client group of Laidlaw Global Securities, a registered broker-dealer. Mr. Perlysky received his Bachelor of Science in Mathematics and Computer Science from the University of Illinois in 1985 and his Master of Science in Management Studies from the J.L. Kellogg School of Management of Northwestern University in 1991.

Basic Compensation

Total Annual Compensation, USD 62,500
Restricted Stock Award, USD 100,000
Long-Term Incentive Plans, USD --
All Other, USD --
Fiscal Year Total, USD 162,500

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Barry Weiner

1,246,880

Elazar Rabbani

1,476,670

James O'Brien

494,722

Bruce Dey

496,496

Dieter Schapfel

470,076

Gregory Bortz

197,500
As Of  31 Jul 2018